These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26939107)

  • 21. [Glucocorticoid-induced osteoporosis and bone mineral densimetry].
    Tanaka I; Oshima H
    Clin Calcium; 2004 Dec; 14(12):77-82. PubMed ID: 15577178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Steroids as a risk factor for osteoporotic fracture].
    Muraki S; Yoshimura N
    Clin Calcium; 2006 Nov; 16(11):1797-1803. PubMed ID: 17079845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid-induced osteoporosis.
    de Gregório LH; Lacativa PG; Melazzi AC; Russo LA
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):793-801. PubMed ID: 17117304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S
    Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study.
    Koh JW; Kim J; Cho H; Ha YC; Kim TY; Lee YK; Kim HY; Jang S
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):562-570. PubMed ID: 32981298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of glucocorticoid-induced osteoporosis.
    Civitelli R; Ziambaras K
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):2-6. PubMed ID: 18791344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of glucocorticoid-induced osteoporosis.
    Messina OD; Vidal LF; Wilman MV; Bultink IEM; Raterman HG; Lems W
    Aging Clin Exp Res; 2021 Apr; 33(4):793-804. PubMed ID: 33751462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glucocorticoid and Bone. Fracture risk of steroid-induced osteoporosis].
    Fujiwara S
    Clin Calcium; 2014 Sep; 24(9):1295-300. PubMed ID: 25177001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis management among chronic glucocorticoid users: a systematic review.
    Albaum JM; Youn S; Levesque LE; Gershon AS; Cadarette SM
    J Popul Ther Clin Pharmacol; 2014; 21(3):e486-504. PubMed ID: 25527817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid-induced osteoporosis and its treatment.
    Pennisi P; Trombetti A; Rizzoli R
    Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guidelines on the management and treatment of glucocorticoid-induced osteoporosis (2004) in Japan].
    Takayanagi R
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():50-5. PubMed ID: 18161081
    [No Abstract]   [Full Text] [Related]  

  • 37. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis.
    McDonough RP; Doucette WR; Kumbera P; Klepser DG
    Value Health; 2005; 8(1):24-31. PubMed ID: 15841891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan.
    Chitre MM; Hayes W
    J Manag Care Pharm; 2008 Apr; 14(3):281-90. PubMed ID: 18439050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.